Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Endoscopic Devices, commonly known as Cambridge Endo, was a medical technology firm focused on the design and manufacture of advanced laparoscopic surgical tools. The company's core product line, the Autonomy Laparo-Angle, featured hand-held articulating instruments that provided surgeons with seven degrees of freedom, significantly enhancing dexterity during minimally invasive procedures. By offering robotic-like maneuverability in a disposable, ergonomic format, the technology aimed to improve surgical precision while reducing costs compared to large-scale robotic systems. In 2011, the company was acquired by Hologic for its GYN surgical division. The acquisition allowed Hologic to expand its portfolio of minimally invasive solutions for gynecological and general surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambridge Endo.